Benchmark Reiterates Speculative Buy Rating on Unicycive Therapeutics (UNCY)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| (NASDAQ: UNCY) | Delayed: 4.19 -0.03 (0.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.22 | 52 Week High | $ | |||
| Open | $4.22 | 52 Week Low | $ | |||
| Day High | $4.28 | P/E | N/A | |||
| Day Low | $4.12 | EPS | $ | |||
| Volume | 681,402 | |||||
